The purpose of this thesis is to check the readiness of a medium size family company, H Biotechnology Company, for initial public offering (IPO). In recent, like most of small and medium size companies, H Company faces a bottleneck to grow due to difficulties of recruiting suitable elites as well as raising money from financing channels. Moreover, it is also not an easy task for an unknown medium size company to initiate transactions with big or foreign companies that did not have any cooperation experience before; however, it is the road a medium size company must take in order to grow well. Therefore, IPO is an option that H Company must take into consideration. Starting from preparation to IPO, the company will scan itself from bottom up thoroughly and make positive changes accordingly throughout the process. Once IPO successfully, there will be more chances and resources for the company to recruit talents and grow. Through preliminary scan in this thesis, hope to point out some parts that H Company has to improve in order to IPO in the near future.
1. Regulations from Taiwan Stock Exchange (http://www.twse.com.tw) 2. Regulations from Taipei Exchange (http://www.tpex.org.tw) 3. 2017生技產業白皮書 by經濟部生技醫藥產業發展推動小組(http://www.biopharm.org.tw) 4. 2017 中小企業白皮書 by 經濟部中小企業處 (http://www.moeasmea.gov.tw)